Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
13.68
+0.44 (3.32%)
Jun 29, 2026, 3:00 PM CST
SHA:600535 Market Cap
SHA:600535 has a market cap or net worth of 20.44 billion as of June 29, 2026. Its market cap has decreased by -16.23% in one year.
Market Cap
20.44B
Enterprise Value
17.37B
Revenue
8.35B
Ranking
n/a
PE Ratio
17.61
Stock Price
13.68
Market Cap Chart
Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 20.44B, an increase of 460.23%. That is a compound annual growth rate of 8.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 20.44B | -9.22% |
| Dec 31, 2025 | 22.51B | 4.22% |
| Dec 31, 2024 | 21.60B | -15.04% |
| Dec 29, 2023 | 25.43B | 59.04% |
| Dec 30, 2022 | 15.99B | -32.76% |
| Dec 31, 2021 | 23.78B | 6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 22.81B |
| Zhejiang Huahai Pharmaceutical | 20.88B |
| Jilin Aodong Pharmaceutical Group | 20.56B |
| Guangdong Zhongsheng Pharmaceutical | 19.20B |
| Shanghai Haoyuan Chemexpress | 19.12B |
| Walvax Biotechnology | 18.66B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 18.52B |
| Chengdu Kanghong Pharmaceutical Group | 17.98B |